Stock ATH ALTERITY THERAPEUTICS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Alterity Therapeutics Limited

Equities

ATH

AU0000043945

Market Closed - Australian S.E.
Other stock markets
 07:59:56 2024-05-19 pm EDT 		5-day change 1st Jan Change
0.005 AUD 0.00% Intraday chart for Alterity Therapeutics Limited 0.00% -28.57%
May. 08 Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review CI
May. 08 Alterity Therapeutics on Track to Complete Phase Two Trial of Lead Drug Candidate in November MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ladenburg Thalmann Initiates Alterity Therapeutics at Buy With $2 Price Target
MT
Goldman Sachs Adjusts Alterity Therapeutics' Price Target to $3 from $11, Keeps Neutral Rating
MT
Australian Shares Fall After US Fed Signals Earlier-than-Expected Rate Hike
MT
ALTERITY THERAPEUTICS : Benchmark Starts Alterity Therapeutics at Speculative Buy With $4 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ATH Stock
  4. News Alterity Therapeutics Limited
  5. Analyst Reco.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW